SuspensionClinical Overview
Levocloperastine (20mg/5ml) and Levodropropizine (30mg/5ml) Syrup is a non-opioid peripheral and central antitussive on the PMBI formulary. Acts primarily on peripheral sensory receptors in the tracheobronchial tree (inhibiting C-fiber sensory neuropeptide release) and selectively suppresses the central cough center without causing sedation, somnolence, respiratory depression, or constipation. Indicated for symptomatic treatment of irritating dry non-productive cough of various etiologies.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally 5 to 10 mL three times daily between meals with water. Measure accurately.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Mild nausea, drowsiness, dizziness, palpitations, dry mouth. Safe non-narcotic profile.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in patients with severe bronchorrhea, Kartagener's syndrome, pregnancy, and nursing mothers.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.